Found: 22
Select item for more details and to access through your institution.
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40061-y
- By:
- Publication type:
- Article
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies.
- Published in:
- Endocrinology, 2024, v. 165, n. 6, p. 1, doi. 10.1210/endocr/bqae051
- By:
- Publication type:
- Article
Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status.
- Published in:
- Drug Design, Development & Therapy, 2022, v. 16, p. 2933, doi. 10.2147/DDDT.S380925
- By:
- Publication type:
- Article
How drug resistance takes shape.
- Published in:
- eLife, 2016, p. 1, doi. 10.7554/eLife.14973
- By:
- Publication type:
- Article
The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast Cancer.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 5, p. 1, doi. 10.1007/s11912-017-0591-8
- By:
- Publication type:
- Article
Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. e441, doi. 10.1634/theoncologist.2018-0363
- By:
- Publication type:
- Article
ESR1 fusions and therapeutic resistance in metastatic breast cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 12, p. 1, doi. 10.3389/fonc.2022.1037531
- By:
- Publication type:
- Article
Digital Quantification of Gene Expression in Sequential Breast Cancer Biopsies Reveals Activation of an Immune Response
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064225
- By:
- Publication type:
- Article
The Evolving Use of SERDs in Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 7, p. 428
- By:
- Publication type:
- Article
VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis.
- Published in:
- BMC Bioinformatics, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s12859-018-2139-9
- By:
- Publication type:
- Article
Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0075-5
- By:
- Publication type:
- Article
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43324-w
- By:
- Publication type:
- Article
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43324-w
- By:
- Publication type:
- Article
Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
- Published in:
- Breast Cancer Research, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13058-014-0508-5
- By:
- Publication type:
- Article
Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Auricular Acupuncture During Chemotherapy Infusion in Breast Cancer Patients: A Feasibility Study.
- Published in:
- Journal of Integrative & Complementary Medicine, 2022, v. 28, n. 5, p. 427, doi. 10.1089/jicm.2021.0256
- By:
- Publication type:
- Article
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00647-1
- By:
- Publication type:
- Article
The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00520-7
- By:
- Publication type:
- Article
The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Are We Ready to Use ESR1 Mutations in Clinical Practice?
- Published in:
- Breast Care, 2017, v. 12, n. 5, p. 309, doi. 10.1159/000481428
- By:
- Publication type:
- Article